Dynavax Technologies Corporation - Common Stock (NQ:DVAX)

15.39 +4.26 (+38.32%)

Streaming Delayed Price Updated: 11:25 AM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Volume	19,540,353
Open	15.49
Bid (Size)	15.39 (16,000)
Ask (Size)	15.40 (19,400)
Prev. Close	11.13
Today's Range	15.38 - 15.49
52wk Range	9.200 - 14.63
Shares Outstanding	128,489,060
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Which stocks are gapping on Wednesday? ↗

Today 10:30 EST

Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

Sanofi’s $2.2 Billion Strategic Pivot: Deconstructing the Dynavax Acquisition and the Future of Specialty Medicine

Today 10:23 EST

As of today, December 24, 2025, the global pharmaceutical landscape is witnessing a profound consolidation of power within specialty medicine and immunology. Sanofi (NASDAQ: SNY; Euronext: SAN), the...

Via PredictStreet

Performance

YTD	+19.3%	+19.3%
1 Month	+34.6%	+34.6%
3 Month	+60.5%	+60.5%
6 Month	+55.3%	+55.3%
1 Year	+20.0%	+20.0%

More News

Dynavax Technologies: Analyzing the 39% Surge and Sanofi Acquisition

Today 10:21 EST

Via PredictStreet

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Dynavax’s Experimental Shingles Vaccine Shows Positive Results In Study: Retail Expects Stock Rally To Continue Into Friday ↗

August 21, 2025

Via Stocktwits

Sanofi Acquires Dynavax in $2.2 Billion Christmas Eve Deal, Sending Shares Soaring

Today 10:12 EST

Via MarketMinute

These stocks that are showing activity before the opening bell on Wednesday. ↗

Today 8:30 EST

Via Chartmill

Why Did Dynavax Stock Surge 38% In Premarket Today? ↗

Today 5:56 EST

Via Stocktwits

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

DVAX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Dynavax Technologies Corporation is Fair to Shareholders

Today 5:31 EST

From Halper Sadeh LLC

Via Business Wire

Nasdaq, S&P 500 Futures Head Into Christmas Eve With Caution: Why ASTS, DVAX, ABVX, PATH, GOOGL Are On Traders' Radar Today ↗

Today 3:45 EST

Via Stocktwits

Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths ↗

December 01, 2025

Via Investor's Business Daily

Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough' ↗

September 26, 2025

Via Benzinga

Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What I Feel' ↗

September 22, 2025

Via Benzinga

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?' ↗

September 18, 2025

Via Benzinga

Dynavax Says Investigational Shingles Vaccine At Par With GSK's Vaccine In Early-Stage Study ↗

August 21, 2025

Via Benzinga

Dynavax (DVAX) Q2 Revenue Jumps 29% ↗

August 07, 2025

Via The Motley Fool

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

June 09, 2025

From Deep Track Capital, LP

Via Business Wire

Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies

June 04, 2025

From Deep Track Capital, LP

Via Business Wire

Deep Track Capital Comments on ISS Recommendation

May 23, 2025

From Deep Track Capital, LP

Via Business Wire

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

May 15, 2025

From Deep Track Capital, LP

Via Business Wire

Breaking Down Dynavax Technologies: 5 Analysts Share Their Views ↗

May 07, 2025

Via Benzinga

Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation ↗

May 07, 2025

Via Benzinga

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

May 06, 2025

From Deep Track Capital, LP

Via Business Wire

Frequently Asked Questions

Is Dynavax Technologies Corporation - Common Stock publicly traded?

Yes, Dynavax Technologies Corporation - Common Stock is publicly traded.

What exchange does Dynavax Technologies Corporation - Common Stock trade on?

Dynavax Technologies Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Dynavax Technologies Corporation - Common Stock?

The ticker symbol for Dynavax Technologies Corporation - Common Stock is DVAX on the Nasdaq Stock Market

What is the current price of Dynavax Technologies Corporation - Common Stock?

The current price of Dynavax Technologies Corporation - Common Stock is 15.39

When was Dynavax Technologies Corporation - Common Stock last traded?

The last trade of Dynavax Technologies Corporation - Common Stock was at 12/24/25 11:25 AM ET

What is the market capitalization of Dynavax Technologies Corporation - Common Stock?

The market capitalization of Dynavax Technologies Corporation - Common Stock is 1.98B

How many shares of Dynavax Technologies Corporation - Common Stock are outstanding?

Dynavax Technologies Corporation - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.